Literature DB >> 25155183

Actigraphy for measurements of sleep in relation to oncological treatment of patients with cancer: a systematic review.

Michael T Madsen1, Chenxi Huang2, Ismail Gögenur2.   

Abstract

Sleep disturbances are a prevalent and disabling problem for patients with cancer. Sleep disturbances are present throughout the cancer trajectory, especially during oncological treatment. Previously sleep disturbances have primarily been quantified with subjective rating scales. Actigraphy is an easy to use, non-invasive method for objective measurement of sleep. We systematically reviewed the literature for studies using actigraphy to measure sleeping habits of patients with cancer, undergoing oncological treatment. Our study furthermore reviewed studies with interventions designed to reduce sleep disturbances in the patient population. 19 studies were included in the final review of which 13 had a descriptive study design and six included some kind of intervention. The studies were primarily performed in patients with breast cancer undergoing chemotherapy. We found that sleep disturbances are prevalent, and persistent in patients with cancer. The sleep disturbances seem to be aggravated by chemotherapy treatment and accumulate as the treatment continues. Sleep disturbances need further attention among clinicians working with patients with cancer.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Actigraphy; Cancer; Oncological treatment; Sleep disturbances

Mesh:

Year:  2014        PMID: 25155183     DOI: 10.1016/j.smrv.2014.07.002

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  15 in total

1.  Agreement between actigraphic and polysomnographic measures of sleep in adults with and without chronic conditions: A systematic review and meta-analysis.

Authors:  Samantha Conley; Andrea Knies; Janene Batten; Garrett Ash; Brienne Miner; Youri Hwang; Sangchoon Jeon; Nancy S Redeker
Journal:  Sleep Med Rev       Date:  2019-05-13       Impact factor: 11.609

2.  Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.

Authors:  Manali A Bhave; Kelly A Speth; Kelley M Kidwell; Angela Lyden; Cindy Alsamarraie; Susan L Murphy; N Lynn Henry
Journal:  Clin Breast Cancer       Date:  2017-12-27       Impact factor: 3.225

3.  Sleep Disturbances in Patients With Coronary Heart Disease: A Systematic Review.

Authors:  Michael Tilling Madsen; Chenxi Huang; Graziella Zangger; Ann Dorthe Olsen Zwisler; Ismail Gögenur
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

Review 4.  Systems Chronotherapeutics.

Authors:  Annabelle Ballesta; Pasquale F Innominato; Robert Dallmann; David A Rand; Francis A Lévi
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

5.  Effect of Melatonin on Sleep in the Perioperative Period after Breast Cancer Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Michael Tvilling Madsen; Melissa Voigt Hansen; Lærke Toftegård Andersen; Ida Hageman; Lars Simon Rasmussen; Susanne Bokmand; Jacob Rosenberg; Ismail Gögenur
Journal:  J Clin Sleep Med       Date:  2016-02       Impact factor: 4.062

6.  Sleep and health-related factors in overweight and obese rural women in a randomized controlled trial.

Authors:  Marcia Y Shade; Ann M Berger; Paul J Dizona; Bunny J Pozehl; Carol H Pullen
Journal:  J Behav Med       Date:  2015-12-11

7.  Exercise for Toxicity Management in Cancer-A Narrative Review.

Authors:  Ian R Kleckner; Richard F Dunne; Matthew Asare; Calvin Cole; Fergal Fleming; Chunkit Fung; Po-Ju Lin; Karen M Mustian
Journal:  Oncol Hematol Rev       Date:  2018-02-15

8.  Exploring sleep disturbance among adults with primary or secondary malignant brain tumors and their caregivers.

Authors:  Megan S Jeon; Haryana M Dhillon; Eng-Siew Koh; Anna K Nowak; Elizabeth Hovey; Joseph Descallar; Lisa Miller; Nathaniel S Marshall; Meera R Agar
Journal:  Neurooncol Pract       Date:  2020-09-12

9.  The effect of MElatonin on Depressive symptoms, Anxiety, CIrcadian and Sleep disturbances in patients after acute coronary syndrome (MEDACIS): study protocol for a randomized controlled trial.

Authors:  Michael Tvilling Madsen; Anders Isbrand; Ulla Overgaard Andersen; Lars Juel Andersen; Mustafa Taskiran; Erik Simonsen; Ismail Gögenur
Journal:  Trials       Date:  2017-02-23       Impact factor: 2.279

Review 10.  Are Sleep Complaints Related to Cognitive Functioning in Non-Central Nervous System Cancer? A Systematic Review.

Authors:  Mylène Duivon; Bénédicte Giffard; Béatrice Desgranges; Joy Perrier
Journal:  Neuropsychol Rev       Date:  2021-08-05       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.